Cabot Profit Booster 193

The one trade from the September expiration cycle that was not closed last week was CFX, which leaves us with the stock and no option position. While it is possible that CFX will rebound in the days/weeks to come, because of the market weakness, am...
Read More

Can LEAPS Investing Be a Substitute for Buying Stock?

Can LEAPS Investing Be a Substitute for Buying Stock?

LEAPS investing can be an effective portfolio strategy for investing in high-growth stocks while reducing your overall portfolio exposure by trading one type of risk for another. We’ve written before on the idea of using a LEAPS investing strategy for longer-term speculative investments but question...
Read More

Cabot Undervalued Stocks Advisor Weekly Update

After a stunningly strong market so far this year, with the S&P 500 producing a 20% total return through Monday, the slow grind-down of most stocks since early September has seemed interminable. The 1,100 largest stocks in our 3,000-stock database have declined only in...
Read More

Cabot Early Opportunities Special Bulletin

Today we’re stepping away from our remaining three-quarter position in long-term holding 10X Genomics (TXG), which we added in December 2019. The stock has been moving sideways since January, and this week management spoke at conferences and suggested it is seeing lower-than-expected lab during...
Read More

Cabot Explorer 744

With more than 10,000 baby boomers reaching 65 each day in America, you can bet that medical services aimed at this giant group are growth markets.
Read More

Cabot Dividend Investor Weekly Update

So far, the post-Labor Day market has been just a little bit crummy. Stocks have drifted slightly lower over the past week. While that’s nothing alarming, it is a reversal of the summer market where stocks were drifting slightly higher. It could be the...
Read More

Cabot Income Advisor Weekly Update

Here we are in September. So far, it’s not bad. But it’s not good either. For the first week after Labor Day, the market has drifted lower. It’s no big deal. But stocks have been losing a battle they were winning in the The...
Read More